Intravaginal misoprostol can reduces blood loss in myomectomy

Intravaginal misoprostol reduces intraoperative blood loss in myomectomy .

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013100714927N1

Enrollment

Registered

2013-11-27

Start date

2013-10-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterus myoma. D25.1 Intramural leiomyoma of uterus D25.2 Subserosal leiomyoma of uterus

Interventions

Intervention 1: Intervention group : Intravaginal Misoprostol

200mig 3 hourse before operation . Intervention 2: Control group : Intravaginal Vit B6 ( pelacebo ) 3 hourse before operation .

Treatment - Drugs

Placebo

Intervention group : Intravaginal Misoprostol

200mig 3 hourse before operation .

Control group : Intravaginal Vit B6 ( pelacebo ) 3 hourse before operation .

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria : Women with intramural or subsrosal uterus myoma that they are the case of laparatomy myomectomy . Exclusion criteria : Vaginal myomectomy ; Myomectomy assisted by hysteroscopy ; Virginity ; Misoprostol contraindications : liver diseas ; Epilepsy ; Sesnsitivity to misoprostol .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hemoglobin count . Timepoint: Hemoglobin before & 6 houre & 12 houerafter operation. Method of measurement: Blood examination.	—

Secondary

Measure	Time frame
Operation time. Timepoint: Intraoperative. Method of measurement: Time.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHajihashima

Tehran university of medical sciences

Hajihashima@yahoo.com+98 21 8831 3766

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026